market perform
reason report
margin risk price squishi u/g op pt
bottom line upgrad outperform rais
pt see margin risk
kept us sidelin final price stock soft
perform ytd clearli exchang busi earn
high singl digit margin overal blend margin remain
flattish suggest margin compress base medicaid book
blend price medicaid like lag low singl
digit cost trend focu margin improv
sg leverag medic cost structur improv
peer wcg op op encourag
bless consensu ep commentari expect
revenu could even exceed offset potenti margin
compress increas ep rais
revenu increas margin given
manag expect hix margin steadi
expect upgrad star sg leverag
grow book offer margin normal around bp
continu ss top-lin growth mid- high-singl
digit core medicaid book still solid good probabl nc
contract award due earli februari offer potenti upsid
tx like larg retain though
possibl region two risk though risk tx rfp hix
polici manag balanc sheet solid debt
cap ratio cfo adj ni dcp
pois normal see stock
attract valu bull may given trade similar p/
 valuat reflect margin downsid like
revers margin expans valu revis
ep upcom catalyst dec i-day tx contract
award nc award februari
margin risk highlight price
miss one-tim tax rate off-set would
like miss increment tax rate suggest miss
deduct transact cost absenc hipf fide
given not-for-profit statu result posit surpris tax
line item ep one-tim tailwind mm ca
ihss off-set va contract charit foundat charg see
street final recogn outsiz exchang margin expans
mask margin pressur base medicaid like medicar
net debt total capit
price-to-earnings lt ep growth
ep
gener long term ep growth period
compani inform leerink partner llc research
revenu billion adj ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
ep achiev bless consensu
manag see upsid top line offset
margin pressur exchang medicaid medicar
downgrad encourag bless consensu ep
commentari expect revenu could
even exceed offset potenti margin compress
increas ep rais revenu
 increas margin given manag
expect hix margin steadi revenu exce
 guidanc fide annual centurion pa
growth mid- high-singl digit ss medicaid growth
medicar advantag hix growth sell season exhibit
offer potenti margin expans recoveri
like focu sg leverag expect upgrad
star sg leverag grow book offer
margin normal around bp continu ss top-
line growth mid- high-singl digit core medicaid book
still solid good probabl nc contract award due earli
februari tx like larg
retain though possibl region two risk exhibit
elect like posit catalyst medicaid expans
possibl post win state ga ne manag
medicaid stock upsid wave
come pass pleas see link report surf elect
servic busi envolv distinct offer growth
envolv suit servic across us medic manag
manag acaria rx advanc roll broadli
interpreta clinic genom provid distinct
margin room improv exhibit
balanc sheet healthi across leverag cfo balanc
sheet solid debt cap ratio
cfo adj ni dcp pois normal
tuck-in acquisit accret roll-up region medicaid
plan fide alway like upsid event exhibit
valuat reflect margin downsid risk upgrad op
see stock attract valu bull may
given trade similar price-to-earnings normal ep
post-turnaround wcg pois substanti
ep upsid next two year margin expans
diversif tailwind part
hix downsid valu price-to-earnings ep
upcom catalyst dec i-day tx contract award
nc award februari exhibit
upgrad outperform rais pt see margin risk
kept us sidelin final price stock soft perform
ytd clearli exchang busi earn high singl digit margin overal
blend margin remain flattish suggest margin compress base medicaid book
blend price medicaid like lag low singl digit cost trend
focu margin improv sg leverag medic cost structur
improv peer wcg encourag bless
consensu ep commentari expect revenu could even exceed
 offset potenti margin compress
increas ep rais revenu increas
margin given manag expect hix margin steadi
also introduc quarterli estim first time expect
upgrad star sg leverag grow book offer margin
normal around bp continu ss top-lin growth mid- high-
singl digit core medicaid book still solid good probabl nc contract award
due earli februari offer potenti upsid tx
like larg retain though possibl region two risk though risk tx rfp
hix polici manag balanc sheet solid debt cap ratio
cfo adj ni dcp pois normal
see stock attract valu bull may given trade similar
price-to-earnings normal ep post-turnaround valuat reflect
margin downsid like revers margin expans valu
revis ep upcom catalyst dec i-day tx contract award
nc award februari
margin risk highlight price miss one-tim
tax rate off-set like miss increment tax rate suggest miss
deduct transact cost absenc hipf fide given not-for-profit
statu result posit surpris tax line item ep one-tim tailwind
mm ca ihss off-set va contract charit foundat charg see street
final recogn outsiz exchang margin expans mask margin pressur
base medicaid like medicar advantag segment
one-tim tax rate off-set like miss
estim bp due one-tim benefit
corpearningsreport estimatesstreet account consensusreport sequentialreport yoypremium servic revenu revenu ep share interest expens invest incom estim corpmetricsreport estimatesstreet account consensusreport sequentialreport yoykey metricsconsolid bpsservic revenu bpsadj bpstax bpsday claim cfo/net corpor
dcp improv day sequenti day larg due fide acquisit
compani rais ep guidanc midpoint reflect
april june daya juli oct estimatesconsensu estimatestot revenu expens ratio expens ratio excl acquisit relat tax share outstand compani guidancereportedconsensusleerink oldleerink newconsensusleerink oldleerink newrevenu incom non-gaap growth centen corpor
ep achiev bless consensu manag see upsid
top line offset margin pressur exchang medicaid medicar
downgrad encourag bless consensu ep
commentari expect revenu could even exceed offset potenti margin
compress increas ep rais revenu
increas margin given manag expect hix margin
steadi revenu exce guidanc fide annual centurion
pa growth mid- high-singl digit ss medicaid growth medicar advantag
hix growth sell season
practic provid full detail updat guidanc decemb investor day still final annual plan process base news date current adjust earn per share consensu would within guidanc rang michael neidorff chairman ceo centen corp centen corpor
visibl revenu
waterfal bncommentscenten stand-alone actual annual fide ltss region start jan organ growth -singl digit growthma growth membershix new member rom new state increas footprint exist state centen corpor
could see margin recoveri recoveri like focu sg
leverag expect upgrad star sg leverag
grow book offer margin normal around bp continu ss
top-lin growth mid- high-singl digit core medicaid book still solid good
probabl nc contract award due earli februari tx
like larg retain though possibl region two risk
member rate
plan
expect increas significantli
note also consid recent acquir fide health plan
recent announc rate posit impact new plan includ jv centurion
membership rate membership rate encourag recent releas data suggest return plan rate plan year expect posit impact multipl new plan includ joint ventur recent establish centurion healthcar michael neidorff chairman ceo centen corp centen corpor
despit expand medicaid nc medicaid program enrol
peopl total annual spend around mm enrolle expect first
contract year despit high minimum enrol limit restrict one
largest state contract come avail year net margin earn potenti
mm assum maximum allow enrol share stake link nc note
believ posit nc rfp due jv carolina complet health
north carolina manag larg program oper earn potenti rang mm
joint ventur carolina complet health establish posit health plan provid medicaid manag care servic state carolina complet submit rfp respons past friday feel well-posit due joint ventur consist local approach furthermor particip north carolina marketplac recogn medicaid rfp score state expect announc winner earli februari neidorff chairman ceo centen corp centen corpor
respons nc dhh medicaid manag rfp due award expect
texa rfp reissu due mid-novemb
implement juli leader revenu
revenu link tx rfp note
tx rfp contract award due
increas hix membership revenu potenti also margin risk
exchang pressur enter new state pa nc sc tn expand
footprint state size market entri yet disclos
new state overal repres around total hix enrol bring hix presenc
state believ recent introduct plan execut order
materi impact enrol given plan provid far better valu target
market larg subsid fpl
right look like -- know rfp reissu due mid-novemb expect award go come right project start date star plu chip rfp schwanek evp cfo centen centen corpor
announc entri hix market new state pa nc sc tn expans
presenc state fl ga ks mo tx bring total hix state
view short-term limit durat plan materi threat enrol
provid valu member fpl
ascens health largest cathol non-profit health system countri
announc letter intent loi explor creation joint ventur medicar
advantag plan serv multipl market view posit
manag follow recent commentari acceler growth
larg grow lucr market strategi offer window potenti futur
vertic combin among payor provid seek combin underwrit rx
benefit popul health manag capabl provid network health
system support recent acquisit cathol health plan fide expect
serv medicar beneficiari revenu exposur end
across state notabl ascens presenc state togeth
penetr rate joint ventur well posit combat typic payor-provid
challeng gop polici drive tailwind underwrit
technolog expertis combin ascens provid network clinic capabl
could time creat signific integr payer/provid entiti previous unseen outsid
think may recal elimin preexist condit alway popular part nation poll broader implic see thing work result result believ extrem well-posit move forward marketplac product futur growth profit mani reason -kevin counihan senior vice presid product centen corpor
overlap ascens servic area state wa az tx co mo ar la al il wi mi
ny fl ga state averag penetr rate us averag
elect like posit catalyst medicaid expans possibl post win
state ga ne manag medicaid stock upsid
wave come pass three potenti scenario hous senat flip price
red supermajor continu price purpl hous flip price
possibl midterm
wave portend red state medicaid expans includ fl id ne ut
well protect futur scotu judici legisl downsid exchang
potenti democrat supermajor pleas link report surf
servic busi envolv distinct offer growth envolv suit servic
across us medic manag acaria rx advanc roll
broadli interpreta clinic genom provid distinct margin
room improv
balanc sheet healthi across leverag cfo balanc sheet solid
debt cap ratio cfo adj ni dcp pois
normal
tuck-in acquisit accret roll-up region medicaid plan fide
debt capit end
ratio remain solid
valuat reflect margin downsid risk upgrad op see stock
attract valu bull may given trade similar price-to-earnings
normal ep post-turnaround wcg pois substanti ep
upsid next two year margin expans diversif tailwind
part hix downsid valu price-to-earnings ep
upcom catalyst dec i-day tx contract award nc award februari
trade price-to-earnings consensu ep
note rel
centen corpor incom statement except oper tax health insur cnc-hnt transact incom net incom net averag share ep dilut growth net profit growth centen corpor
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
aggress share repurchas use solid parent cash posit debt rais
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
new pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
base price-to-earnings multipl appli stand-alone ep rate ci
outperform price target
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price target base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
